Pfizer surrenders neratinib to Puma which raises $55m for new development plan
06 October 2011
Sukaina Virji
Please Login to read the full article.
06 October 2011
Sukaina Virji
Please Login to read the full article.
RELATED CONTENT
NEWS
- Exelixis details cabozantinib clinical roadmap
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- One down, two to go: startup Tolero licenses one of MannKind's cancer programmes
- Clovis' $75M offering follows IPO, as pancreatic cancer candidate could carve out a niche
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
